nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Epirubicin—thyroid cancer	0.145	0.52	CrCtD
Daunorubicin—Doxorubicin—thyroid cancer	0.134	0.481	CrCtD
Daunorubicin—Anthracyclines—Epirubicin—thyroid cancer	0.117	0.341	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—thyroid cancer	0.108	0.316	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—thyroid cancer	0.0611	0.178	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—thyroid cancer	0.0565	0.165	CiPCiCtD
Daunorubicin—YWHAG—Epirubicin—thyroid cancer	0.0434	0.283	CbGbCtD
Daunorubicin—Doxorubicin—Epirubicin—thyroid cancer	0.0311	0.173	CrCrCtD
Daunorubicin—Valrubicin—Epirubicin—thyroid cancer	0.0311	0.173	CrCrCtD
Daunorubicin—Idarubicin—Epirubicin—thyroid cancer	0.0311	0.173	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—thyroid cancer	0.0288	0.16	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—thyroid cancer	0.0288	0.16	CrCrCtD
Daunorubicin—Idarubicin—Doxorubicin—thyroid cancer	0.0288	0.16	CrCrCtD
Daunorubicin—YWHAG—Doxorubicin—thyroid cancer	0.023	0.15	CbGbCtD
Daunorubicin—POR—Doxorubicin—thyroid cancer	0.00957	0.0625	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—thyroid cancer	0.00881	0.0575	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—thyroid cancer	0.00879	0.0574	CbGbCtD
Daunorubicin—ABCC1—Vandetanib—thyroid cancer	0.00709	0.0463	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—thyroid cancer	0.00672	0.0439	CbGbCtD
Daunorubicin—XDH—Doxorubicin—thyroid cancer	0.00549	0.0359	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—thyroid cancer	0.00488	0.0319	CbGbCtD
Daunorubicin—ABCG2—Vandetanib—thyroid cancer	0.00475	0.031	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—thyroid cancer	0.00468	0.0305	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—thyroid cancer	0.00365	0.0238	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—thyroid cancer	0.00365	0.0238	CbGbCtD
Daunorubicin—ABCC2—Sorafenib—thyroid cancer	0.00316	0.0207	CbGbCtD
Daunorubicin—ABCG2—Sorafenib—thyroid cancer	0.00286	0.0187	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—thyroid cancer	0.00259	0.0169	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—thyroid cancer	0.00192	0.0125	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—thyroid cancer	0.00174	0.0113	CbGbCtD
Daunorubicin—CYP3A5—Sorafenib—thyroid cancer	0.00159	0.0103	CbGbCtD
Daunorubicin—CYP1A2—Sorafenib—thyroid cancer	0.00118	0.0077	CbGbCtD
Daunorubicin—ABCB1—Sorafenib—thyroid cancer	0.00103	0.00673	CbGbCtD
Daunorubicin—CYP3A4—Vandetanib—thyroid cancer	0.00103	0.00669	CbGbCtD
Daunorubicin—ABCB1—Doxorubicin—thyroid cancer	0.000626	0.00409	CbGbCtD
Daunorubicin—CYP3A4—Sorafenib—thyroid cancer	0.000618	0.00403	CbGbCtD
Daunorubicin—CYP3A4—Doxorubicin—thyroid cancer	0.000375	0.00245	CbGbCtD
Daunorubicin—YWHAG—saliva-secreting gland—thyroid cancer	0.000331	0.0598	CbGeAlD
Daunorubicin—TOP2B—saliva-secreting gland—thyroid cancer	0.000319	0.0576	CbGeAlD
Daunorubicin—NR5A1—head—thyroid cancer	0.000271	0.049	CbGeAlD
Daunorubicin—YWHAG—trachea—thyroid cancer	0.000255	0.0461	CbGeAlD
Daunorubicin—POR—saliva-secreting gland—thyroid cancer	0.000252	0.0454	CbGeAlD
Daunorubicin—TOP2B—trachea—thyroid cancer	0.000246	0.0444	CbGeAlD
Daunorubicin—TOP2A—Erlotinib—Vandetanib—thyroid cancer	0.000223	0.347	CbGdCrCtD
Daunorubicin—ABCC6—thyroid gland—thyroid cancer	0.000215	0.0387	CbGeAlD
Daunorubicin—YWHAG—thyroid gland—thyroid cancer	0.000202	0.0365	CbGeAlD
Daunorubicin—ABCC10—saliva-secreting gland—thyroid cancer	0.0002	0.036	CbGeAlD
Daunorubicin—TOP2B—thyroid gland—thyroid cancer	0.000195	0.0351	CbGeAlD
Daunorubicin—POR—trachea—thyroid cancer	0.000194	0.035	CbGeAlD
Daunorubicin—ABCC6—head—thyroid cancer	0.00019	0.0344	CbGeAlD
Daunorubicin—YWHAG—head—thyroid cancer	0.000179	0.0323	CbGeAlD
Daunorubicin—TOP2B—head—thyroid cancer	0.000173	0.0312	CbGeAlD
Daunorubicin—ABCC10—trachea—thyroid cancer	0.000154	0.0278	CbGeAlD
Daunorubicin—POR—thyroid gland—thyroid cancer	0.000154	0.0277	CbGeAlD
Daunorubicin—TOP2A—Afatinib—Vandetanib—thyroid cancer	0.000146	0.227	CbGdCrCtD
Daunorubicin—TOP2A—thyroid gland—thyroid cancer	0.000143	0.0258	CbGeAlD
Daunorubicin—TOP2A—Gefitinib—Vandetanib—thyroid cancer	0.000127	0.199	CbGdCrCtD
Daunorubicin—YWHAG—lymph node—thyroid cancer	0.000125	0.0227	CbGeAlD
Daunorubicin—ABCC10—thyroid gland—thyroid cancer	0.000122	0.022	CbGeAlD
Daunorubicin—TOP2B—lymph node—thyroid cancer	0.000121	0.0218	CbGeAlD
Daunorubicin—ABCG2—saliva-secreting gland—thyroid cancer	0.000117	0.0211	CbGeAlD
Daunorubicin—ABCC1—trachea—thyroid cancer	0.000109	0.0197	CbGeAlD
Daunorubicin—CYP1B1—thyroid gland—thyroid cancer	9.58e-05	0.0173	CbGeAlD
Daunorubicin—POR—lymph node—thyroid cancer	9.54e-05	0.0172	CbGeAlD
Daunorubicin—TOP2A—lymph node—thyroid cancer	8.89e-05	0.0161	CbGeAlD
Daunorubicin—ABCC1—thyroid gland—thyroid cancer	8.62e-05	0.0156	CbGeAlD
Daunorubicin—CYP1A1—trachea—thyroid cancer	8.56e-05	0.0155	CbGeAlD
Daunorubicin—CYP1B1—head—thyroid cancer	8.5e-05	0.0153	CbGeAlD
Daunorubicin—ABCC10—lymph node—thyroid cancer	7.57e-05	0.0137	CbGeAlD
Daunorubicin—ABCG2—thyroid gland—thyroid cancer	7.13e-05	0.0129	CbGeAlD
Daunorubicin—CYP1A2—thyroid gland—thyroid cancer	6.87e-05	0.0124	CbGeAlD
Daunorubicin—CYP1A1—thyroid gland—thyroid cancer	6.77e-05	0.0122	CbGeAlD
Daunorubicin—ABCC2—lymph node—thyroid cancer	6.08e-05	0.011	CbGeAlD
Daunorubicin—CYP1A1—head—thyroid cancer	6.01e-05	0.0108	CbGeAlD
Daunorubicin—CYP1B1—lymph node—thyroid cancer	5.95e-05	0.0107	CbGeAlD
Daunorubicin—Ulcer—Epirubicin—thyroid cancer	5.4e-05	0.00198	CcSEcCtD
Daunorubicin—ABCC1—lymph node—thyroid cancer	5.35e-05	0.00966	CbGeAlD
Daunorubicin—Loss of consciousness—Sorafenib—thyroid cancer	5.31e-05	0.00195	CcSEcCtD
Daunorubicin—Cough—Sorafenib—thyroid cancer	5.27e-05	0.00194	CcSEcCtD
Daunorubicin—Atrioventricular block—Epirubicin—thyroid cancer	5.27e-05	0.00193	CcSEcCtD
Daunorubicin—Asthenia—Vandetanib—thyroid cancer	5.25e-05	0.00193	CcSEcCtD
Daunorubicin—Gait disturbance—Epirubicin—thyroid cancer	5.23e-05	0.00192	CcSEcCtD
Daunorubicin—Viral infection—Doxorubicin—thyroid cancer	5.23e-05	0.00192	CcSEcCtD
Daunorubicin—Ventricular extrasystoles—Doxorubicin—thyroid cancer	5.23e-05	0.00192	CcSEcCtD
Daunorubicin—Hypertension—Sorafenib—thyroid cancer	5.22e-05	0.00192	CcSEcCtD
Daunorubicin—Blood uric acid increased—Epirubicin—thyroid cancer	5.2e-05	0.00191	CcSEcCtD
Daunorubicin—Cellulitis—Doxorubicin—thyroid cancer	5.2e-05	0.00191	CcSEcCtD
Daunorubicin—Pruritus—Vandetanib—thyroid cancer	5.17e-05	0.0019	CcSEcCtD
Daunorubicin—Thinking abnormal—Doxorubicin—thyroid cancer	5.16e-05	0.0019	CcSEcCtD
Daunorubicin—Myalgia—Sorafenib—thyroid cancer	5.14e-05	0.00189	CcSEcCtD
Daunorubicin—Arthralgia—Sorafenib—thyroid cancer	5.14e-05	0.00189	CcSEcCtD
Daunorubicin—Hiccups—Epirubicin—thyroid cancer	5.11e-05	0.00188	CcSEcCtD
Daunorubicin—Nocturia—Doxorubicin—thyroid cancer	5.1e-05	0.00187	CcSEcCtD
Daunorubicin—Hyperuricaemia—Doxorubicin—thyroid cancer	5.1e-05	0.00187	CcSEcCtD
Daunorubicin—Dermatitis contact—Epirubicin—thyroid cancer	5.05e-05	0.00185	CcSEcCtD
Daunorubicin—Dry mouth—Sorafenib—thyroid cancer	5.03e-05	0.00185	CcSEcCtD
Daunorubicin—Diarrhoea—Vandetanib—thyroid cancer	5e-05	0.00184	CcSEcCtD
Daunorubicin—Ulcer—Doxorubicin—thyroid cancer	5e-05	0.00183	CcSEcCtD
Daunorubicin—Melaena—Epirubicin—thyroid cancer	4.99e-05	0.00183	CcSEcCtD
Daunorubicin—Influenza like illness—Epirubicin—thyroid cancer	4.96e-05	0.00182	CcSEcCtD
Daunorubicin—Anaphylactic shock—Sorafenib—thyroid cancer	4.93e-05	0.00181	CcSEcCtD
Daunorubicin—Infection—Sorafenib—thyroid cancer	4.9e-05	0.0018	CcSEcCtD
Daunorubicin—Atrioventricular block—Doxorubicin—thyroid cancer	4.87e-05	0.00179	CcSEcCtD
Daunorubicin—Shock—Sorafenib—thyroid cancer	4.85e-05	0.00178	CcSEcCtD
Daunorubicin—Gait disturbance—Doxorubicin—thyroid cancer	4.84e-05	0.00178	CcSEcCtD
Daunorubicin—Dizziness—Vandetanib—thyroid cancer	4.83e-05	0.00177	CcSEcCtD
Daunorubicin—Thrombocytopenia—Sorafenib—thyroid cancer	4.83e-05	0.00177	CcSEcCtD
Daunorubicin—Blood uric acid increased—Doxorubicin—thyroid cancer	4.81e-05	0.00177	CcSEcCtD
Daunorubicin—Neuropathy—Epirubicin—thyroid cancer	4.8e-05	0.00176	CcSEcCtD
Daunorubicin—Hiccups—Doxorubicin—thyroid cancer	4.73e-05	0.00174	CcSEcCtD
Daunorubicin—Anorexia—Sorafenib—thyroid cancer	4.7e-05	0.00173	CcSEcCtD
Daunorubicin—Dermatitis contact—Doxorubicin—thyroid cancer	4.67e-05	0.00171	CcSEcCtD
Daunorubicin—Oesophagitis—Epirubicin—thyroid cancer	4.67e-05	0.00171	CcSEcCtD
Daunorubicin—Vomiting—Vandetanib—thyroid cancer	4.65e-05	0.00171	CcSEcCtD
Daunorubicin—Melaena—Doxorubicin—thyroid cancer	4.62e-05	0.00169	CcSEcCtD
Daunorubicin—Rash—Vandetanib—thyroid cancer	4.61e-05	0.00169	CcSEcCtD
Daunorubicin—Dermatitis—Vandetanib—thyroid cancer	4.61e-05	0.00169	CcSEcCtD
Daunorubicin—Influenza like illness—Doxorubicin—thyroid cancer	4.59e-05	0.00169	CcSEcCtD
Daunorubicin—Headache—Vandetanib—thyroid cancer	4.58e-05	0.00168	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	4.49e-05	0.00165	CcSEcCtD
Daunorubicin—Hypertonia—Epirubicin—thyroid cancer	4.48e-05	0.00164	CcSEcCtD
Daunorubicin—Abnormal vision—Epirubicin—thyroid cancer	4.46e-05	0.00164	CcSEcCtD
Daunorubicin—ABCB1—trachea—thyroid cancer	4.45e-05	0.00803	CbGeAlD
Daunorubicin—Neuropathy—Doxorubicin—thyroid cancer	4.44e-05	0.00163	CcSEcCtD
Daunorubicin—Mental disability—Epirubicin—thyroid cancer	4.43e-05	0.00163	CcSEcCtD
Daunorubicin—ABCG2—lymph node—thyroid cancer	4.43e-05	0.008	CbGeAlD
Daunorubicin—Dyspnoea—Sorafenib—thyroid cancer	4.4e-05	0.00161	CcSEcCtD
Daunorubicin—Lymphadenopathy—Epirubicin—thyroid cancer	4.35e-05	0.0016	CcSEcCtD
Daunorubicin—Nausea—Vandetanib—thyroid cancer	4.34e-05	0.00159	CcSEcCtD
Daunorubicin—Oesophagitis—Doxorubicin—thyroid cancer	4.32e-05	0.00159	CcSEcCtD
Daunorubicin—Decreased appetite—Sorafenib—thyroid cancer	4.29e-05	0.00157	CcSEcCtD
Daunorubicin—Thrombophlebitis—Epirubicin—thyroid cancer	4.28e-05	0.00157	CcSEcCtD
Daunorubicin—Fatigue—Sorafenib—thyroid cancer	4.25e-05	0.00156	CcSEcCtD
Daunorubicin—Hepatic function abnormal—Epirubicin—thyroid cancer	4.24e-05	0.00156	CcSEcCtD
Daunorubicin—Constipation—Sorafenib—thyroid cancer	4.22e-05	0.00155	CcSEcCtD
Daunorubicin—Pain—Sorafenib—thyroid cancer	4.22e-05	0.00155	CcSEcCtD
Daunorubicin—CYP1A1—lymph node—thyroid cancer	4.21e-05	0.0076	CbGeAlD
Daunorubicin—Hypertonia—Doxorubicin—thyroid cancer	4.14e-05	0.00152	CcSEcCtD
Daunorubicin—Abnormal vision—Doxorubicin—thyroid cancer	4.12e-05	0.00151	CcSEcCtD
Daunorubicin—Eye pain—Epirubicin—thyroid cancer	4.11e-05	0.00151	CcSEcCtD
Daunorubicin—Mental disability—Doxorubicin—thyroid cancer	4.1e-05	0.00151	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Epirubicin—thyroid cancer	4.09e-05	0.0015	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Sorafenib—thyroid cancer	4.03e-05	0.00148	CcSEcCtD
Daunorubicin—Lymphadenopathy—Doxorubicin—thyroid cancer	4.02e-05	0.00148	CcSEcCtD
Daunorubicin—Hot flush—Epirubicin—thyroid cancer	3.96e-05	0.00146	CcSEcCtD
Daunorubicin—Thrombophlebitis—Doxorubicin—thyroid cancer	3.96e-05	0.00145	CcSEcCtD
Daunorubicin—Increased appetite—Epirubicin—thyroid cancer	3.95e-05	0.00145	CcSEcCtD
Daunorubicin—Menopausal symptoms—Epirubicin—thyroid cancer	3.93e-05	0.00144	CcSEcCtD
Daunorubicin—Hepatic function abnormal—Doxorubicin—thyroid cancer	3.93e-05	0.00144	CcSEcCtD
Daunorubicin—Urticaria—Sorafenib—thyroid cancer	3.92e-05	0.00144	CcSEcCtD
Daunorubicin—Abdominal pain—Sorafenib—thyroid cancer	3.9e-05	0.00143	CcSEcCtD
Daunorubicin—Body temperature increased—Sorafenib—thyroid cancer	3.9e-05	0.00143	CcSEcCtD
Daunorubicin—Renal impairment—Epirubicin—thyroid cancer	3.9e-05	0.00143	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Epirubicin—thyroid cancer	3.83e-05	0.00141	CcSEcCtD
Daunorubicin—Eye pain—Doxorubicin—thyroid cancer	3.8e-05	0.0014	CcSEcCtD
Daunorubicin—Cardiac failure—Epirubicin—thyroid cancer	3.8e-05	0.00139	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Doxorubicin—thyroid cancer	3.78e-05	0.00139	CcSEcCtD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—thyroid cancer	3.78e-05	0.0589	CbGdCrCtD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—thyroid cancer	3.78e-05	0.0589	CbGdCrCtD
Daunorubicin—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	3.71e-05	0.00136	CcSEcCtD
Daunorubicin—Hot flush—Doxorubicin—thyroid cancer	3.67e-05	0.00135	CcSEcCtD
Daunorubicin—Increased appetite—Doxorubicin—thyroid cancer	3.65e-05	0.00134	CcSEcCtD
Daunorubicin—Affect lability—Epirubicin—thyroid cancer	3.65e-05	0.00134	CcSEcCtD
Daunorubicin—Menopausal symptoms—Doxorubicin—thyroid cancer	3.64e-05	0.00133	CcSEcCtD
Daunorubicin—Hypersensitivity—Sorafenib—thyroid cancer	3.63e-05	0.00133	CcSEcCtD
Daunorubicin—Renal impairment—Doxorubicin—thyroid cancer	3.61e-05	0.00132	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Doxorubicin—thyroid cancer	3.55e-05	0.0013	CcSEcCtD
Daunorubicin—Asthenia—Sorafenib—thyroid cancer	3.54e-05	0.0013	CcSEcCtD
Daunorubicin—Cardiac arrest—Epirubicin—thyroid cancer	3.53e-05	0.00129	CcSEcCtD
Daunorubicin—ABCB1—thyroid gland—thyroid cancer	3.52e-05	0.00635	CbGeAlD
Daunorubicin—Cardiac failure—Doxorubicin—thyroid cancer	3.52e-05	0.00129	CcSEcCtD
Daunorubicin—Mood swings—Epirubicin—thyroid cancer	3.51e-05	0.00129	CcSEcCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—thyroid cancer	3.5e-05	0.0545	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—thyroid cancer	3.5e-05	0.0545	CbGdCrCtD
Daunorubicin—Pruritus—Sorafenib—thyroid cancer	3.49e-05	0.00128	CcSEcCtD
Daunorubicin—Ataxia—Epirubicin—thyroid cancer	3.49e-05	0.00128	CcSEcCtD
Daunorubicin—Dehydration—Epirubicin—thyroid cancer	3.45e-05	0.00127	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	3.43e-05	0.00126	CcSEcCtD
Daunorubicin—Dry skin—Epirubicin—thyroid cancer	3.4e-05	0.00125	CcSEcCtD
Daunorubicin—Affect lability—Doxorubicin—thyroid cancer	3.38e-05	0.00124	CcSEcCtD
Daunorubicin—Diarrhoea—Sorafenib—thyroid cancer	3.37e-05	0.00124	CcSEcCtD
Daunorubicin—Gastritis—Epirubicin—thyroid cancer	3.28e-05	0.0012	CcSEcCtD
Daunorubicin—Cardiac arrest—Doxorubicin—thyroid cancer	3.26e-05	0.0012	CcSEcCtD
Daunorubicin—Dizziness—Sorafenib—thyroid cancer	3.26e-05	0.0012	CcSEcCtD
Daunorubicin—Mood swings—Doxorubicin—thyroid cancer	3.25e-05	0.00119	CcSEcCtD
Daunorubicin—Ataxia—Doxorubicin—thyroid cancer	3.23e-05	0.00118	CcSEcCtD
Daunorubicin—Dysphagia—Epirubicin—thyroid cancer	3.2e-05	0.00118	CcSEcCtD
Daunorubicin—Dehydration—Doxorubicin—thyroid cancer	3.19e-05	0.00117	CcSEcCtD
Daunorubicin—Dry skin—Doxorubicin—thyroid cancer	3.14e-05	0.00115	CcSEcCtD
Daunorubicin—Vomiting—Sorafenib—thyroid cancer	3.14e-05	0.00115	CcSEcCtD
Daunorubicin—Angina pectoris—Epirubicin—thyroid cancer	3.12e-05	0.00115	CcSEcCtD
Daunorubicin—ABCB1—head—thyroid cancer	3.12e-05	0.00563	CbGeAlD
Daunorubicin—Rash—Sorafenib—thyroid cancer	3.11e-05	0.00114	CcSEcCtD
Daunorubicin—Dermatitis—Sorafenib—thyroid cancer	3.11e-05	0.00114	CcSEcCtD
Daunorubicin—Headache—Sorafenib—thyroid cancer	3.09e-05	0.00113	CcSEcCtD
Daunorubicin—Pancytopenia—Epirubicin—thyroid cancer	3.04e-05	0.00112	CcSEcCtD
Daunorubicin—Gastritis—Doxorubicin—thyroid cancer	3.04e-05	0.00111	CcSEcCtD
Daunorubicin—Dysuria—Epirubicin—thyroid cancer	3e-05	0.0011	CcSEcCtD
Daunorubicin—Neutropenia—Epirubicin—thyroid cancer	3e-05	0.0011	CcSEcCtD
Daunorubicin—Dysphagia—Doxorubicin—thyroid cancer	2.97e-05	0.00109	CcSEcCtD
Daunorubicin—Nausea—Sorafenib—thyroid cancer	2.93e-05	0.00108	CcSEcCtD
Daunorubicin—Angina pectoris—Doxorubicin—thyroid cancer	2.89e-05	0.00106	CcSEcCtD
Daunorubicin—Pancytopenia—Doxorubicin—thyroid cancer	2.82e-05	0.00103	CcSEcCtD
Daunorubicin—Renal failure—Epirubicin—thyroid cancer	2.81e-05	0.00103	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Epirubicin—thyroid cancer	2.8e-05	0.00103	CcSEcCtD
Daunorubicin—Stomatitis—Epirubicin—thyroid cancer	2.79e-05	0.00102	CcSEcCtD
Daunorubicin—Conjunctivitis—Epirubicin—thyroid cancer	2.78e-05	0.00102	CcSEcCtD
Daunorubicin—Neutropenia—Doxorubicin—thyroid cancer	2.77e-05	0.00102	CcSEcCtD
Daunorubicin—Dysuria—Doxorubicin—thyroid cancer	2.77e-05	0.00102	CcSEcCtD
Daunorubicin—Sinusitis—Epirubicin—thyroid cancer	2.68e-05	0.000984	CcSEcCtD
Daunorubicin—Renal failure—Doxorubicin—thyroid cancer	2.6e-05	0.000954	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Doxorubicin—thyroid cancer	2.59e-05	0.000951	CcSEcCtD
Daunorubicin—Stomatitis—Doxorubicin—thyroid cancer	2.58e-05	0.000946	CcSEcCtD
Daunorubicin—Rhinitis—Epirubicin—thyroid cancer	2.57e-05	0.000944	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—thyroid cancer	2.57e-05	0.000943	CcSEcCtD
Daunorubicin—Sinusitis—Doxorubicin—thyroid cancer	2.48e-05	0.000911	CcSEcCtD
Daunorubicin—Visual impairment—Epirubicin—thyroid cancer	2.47e-05	0.000908	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—thyroid cancer	2.39e-05	0.000878	CcSEcCtD
Daunorubicin—Cardiac disorder—Epirubicin—thyroid cancer	2.38e-05	0.000874	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—thyroid cancer	2.38e-05	0.000874	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—thyroid cancer	2.38e-05	0.000874	CcSEcCtD
Daunorubicin—Chills—Epirubicin—thyroid cancer	2.3e-05	0.000845	CcSEcCtD
Daunorubicin—Arrhythmia—Epirubicin—thyroid cancer	2.29e-05	0.000841	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—thyroid cancer	2.29e-05	0.00084	CcSEcCtD
Daunorubicin—Alopecia—Epirubicin—thyroid cancer	2.27e-05	0.000832	CcSEcCtD
Daunorubicin—Erythema—Epirubicin—thyroid cancer	2.23e-05	0.00082	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—thyroid cancer	2.21e-05	0.000812	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—thyroid cancer	2.2e-05	0.000809	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—thyroid cancer	2.2e-05	0.000809	CcSEcCtD
Daunorubicin—Dysgeusia—Epirubicin—thyroid cancer	2.19e-05	0.000803	CcSEcCtD
Daunorubicin—ABCB1—lymph node—thyroid cancer	2.19e-05	0.00395	CbGeAlD
Daunorubicin—Back pain—Epirubicin—thyroid cancer	2.16e-05	0.000793	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—thyroid cancer	2.13e-05	0.000782	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—thyroid cancer	2.12e-05	0.000778	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—thyroid cancer	2.1e-05	0.00077	CcSEcCtD
Daunorubicin—Ill-defined disorder—Epirubicin—thyroid cancer	2.07e-05	0.000761	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—thyroid cancer	2.07e-05	0.000759	CcSEcCtD
Daunorubicin—Anaemia—Epirubicin—thyroid cancer	2.06e-05	0.000758	CcSEcCtD
Daunorubicin—Agitation—Epirubicin—thyroid cancer	2.05e-05	0.000753	CcSEcCtD
Daunorubicin—Dysgeusia—Doxorubicin—thyroid cancer	2.02e-05	0.000743	CcSEcCtD
Daunorubicin—Malaise—Epirubicin—thyroid cancer	2.01e-05	0.000739	CcSEcCtD
Daunorubicin—Syncope—Epirubicin—thyroid cancer	2e-05	0.000735	CcSEcCtD
Daunorubicin—Leukopenia—Epirubicin—thyroid cancer	2e-05	0.000734	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—thyroid cancer	2e-05	0.000734	CcSEcCtD
Daunorubicin—Palpitations—Epirubicin—thyroid cancer	1.97e-05	0.000724	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—thyroid cancer	1.96e-05	0.000721	CcSEcCtD
Daunorubicin—Cough—Epirubicin—thyroid cancer	1.95e-05	0.000715	CcSEcCtD
Daunorubicin—Convulsion—Epirubicin—thyroid cancer	1.93e-05	0.00071	CcSEcCtD
Daunorubicin—Hypertension—Epirubicin—thyroid cancer	1.93e-05	0.000708	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—thyroid cancer	1.92e-05	0.000704	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—thyroid cancer	1.91e-05	0.000701	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—thyroid cancer	1.9e-05	0.000698	CcSEcCtD
Daunorubicin—Chest pain—Epirubicin—thyroid cancer	1.9e-05	0.000698	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—thyroid cancer	1.9e-05	0.000698	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—thyroid cancer	1.9e-05	0.000697	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—thyroid cancer	1.89e-05	0.000695	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—thyroid cancer	1.88e-05	0.00069	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—thyroid cancer	1.86e-05	0.000684	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—thyroid cancer	1.86e-05	0.000683	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—thyroid cancer	1.85e-05	0.00068	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—thyroid cancer	1.85e-05	0.000679	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—thyroid cancer	1.84e-05	0.000675	CcSEcCtD
Daunorubicin—Palpitations—Doxorubicin—thyroid cancer	1.83e-05	0.00067	CcSEcCtD
Daunorubicin—Anaphylactic shock—Epirubicin—thyroid cancer	1.82e-05	0.000669	CcSEcCtD
Daunorubicin—Oedema—Epirubicin—thyroid cancer	1.82e-05	0.000669	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—thyroid cancer	1.82e-05	0.000667	CcSEcCtD
Daunorubicin—Infection—Epirubicin—thyroid cancer	1.81e-05	0.000665	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—thyroid cancer	1.8e-05	0.000662	CcSEcCtD
Daunorubicin—Shock—Epirubicin—thyroid cancer	1.79e-05	0.000658	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—thyroid cancer	1.79e-05	0.000657	CcSEcCtD
Daunorubicin—Thrombocytopenia—Epirubicin—thyroid cancer	1.78e-05	0.000655	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—thyroid cancer	1.78e-05	0.000655	CcSEcCtD
Daunorubicin—Tachycardia—Epirubicin—thyroid cancer	1.78e-05	0.000653	CcSEcCtD
Daunorubicin—Hyperhidrosis—Epirubicin—thyroid cancer	1.76e-05	0.000647	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—thyroid cancer	1.76e-05	0.000646	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—thyroid cancer	1.76e-05	0.000646	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—thyroid cancer	1.76e-05	0.000646	CcSEcCtD
Daunorubicin—Anxiety—Doxorubicin—thyroid cancer	1.75e-05	0.000644	CcSEcCtD
Daunorubicin—Discomfort—Doxorubicin—thyroid cancer	1.74e-05	0.000638	CcSEcCtD
Daunorubicin—Anorexia—Epirubicin—thyroid cancer	1.74e-05	0.000638	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—thyroid cancer	1.72e-05	0.000632	CcSEcCtD
Daunorubicin—Confusional state—Doxorubicin—thyroid cancer	1.7e-05	0.000624	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—thyroid cancer	1.69e-05	0.000619	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—thyroid cancer	1.69e-05	0.000619	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—thyroid cancer	1.68e-05	0.000615	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	1.66e-05	0.00061	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—thyroid cancer	1.66e-05	0.000609	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—thyroid cancer	1.65e-05	0.000606	CcSEcCtD
Daunorubicin—Insomnia—Epirubicin—thyroid cancer	1.65e-05	0.000605	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—thyroid cancer	1.65e-05	0.000604	CcSEcCtD
Daunorubicin—Hyperhidrosis—Doxorubicin—thyroid cancer	1.63e-05	0.000598	CcSEcCtD
Daunorubicin—Dyspnoea—Epirubicin—thyroid cancer	1.62e-05	0.000596	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—thyroid cancer	1.62e-05	0.000595	CcSEcCtD
Daunorubicin—Anorexia—Doxorubicin—thyroid cancer	1.61e-05	0.00059	CcSEcCtD
Daunorubicin—Decreased appetite—Epirubicin—thyroid cancer	1.58e-05	0.000582	CcSEcCtD
Daunorubicin—Fatigue—Epirubicin—thyroid cancer	1.57e-05	0.000577	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—thyroid cancer	1.56e-05	0.000572	CcSEcCtD
Daunorubicin—Pain—Epirubicin—thyroid cancer	1.56e-05	0.000572	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	1.54e-05	0.000564	CcSEcCtD
Daunorubicin—Insomnia—Doxorubicin—thyroid cancer	1.53e-05	0.00056	CcSEcCtD
Daunorubicin—Dyspnoea—Doxorubicin—thyroid cancer	1.5e-05	0.000552	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—thyroid cancer	1.5e-05	0.000551	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—thyroid cancer	1.5e-05	0.00055	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—thyroid cancer	1.49e-05	0.000547	CcSEcCtD
Daunorubicin—Decreased appetite—Doxorubicin—thyroid cancer	1.47e-05	0.000538	CcSEcCtD
Daunorubicin—Fatigue—Doxorubicin—thyroid cancer	1.45e-05	0.000534	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—thyroid cancer	1.45e-05	0.000531	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—thyroid cancer	1.44e-05	0.000529	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—thyroid cancer	1.44e-05	0.000529	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—thyroid cancer	1.44e-05	0.000529	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—thyroid cancer	1.44e-05	0.000529	CcSEcCtD
Daunorubicin—Feeling abnormal—Doxorubicin—thyroid cancer	1.39e-05	0.00051	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—thyroid cancer	1.38e-05	0.000506	CcSEcCtD
Daunorubicin—Hypersensitivity—Epirubicin—thyroid cancer	1.34e-05	0.000493	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—thyroid cancer	1.34e-05	0.000492	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—thyroid cancer	1.33e-05	0.000489	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—thyroid cancer	1.33e-05	0.000489	CcSEcCtD
Daunorubicin—ABCC1—Metabolism—MINPP1—thyroid cancer	1.33e-05	0.00114	CbGpPWpGaD
Daunorubicin—Asthenia—Epirubicin—thyroid cancer	1.31e-05	0.00048	CcSEcCtD
Daunorubicin—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.29e-05	0.0011	CbGpPWpGaD
Daunorubicin—Pruritus—Epirubicin—thyroid cancer	1.29e-05	0.000473	CcSEcCtD
Daunorubicin—CYP1B1—Metabolism—MINPP1—thyroid cancer	1.28e-05	0.0011	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CHST14—thyroid cancer	1.27e-05	0.00108	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDK1—thyroid cancer	1.25e-05	0.00107	CbGpPWpGaD
Daunorubicin—Diarrhoea—Epirubicin—thyroid cancer	1.25e-05	0.000458	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—thyroid cancer	1.24e-05	0.000456	CcSEcCtD
Daunorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.23e-05	0.00105	CbGpPWpGaD
Daunorubicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.22e-05	0.00105	CbGpPWpGaD
Daunorubicin—Asthenia—Doxorubicin—thyroid cancer	1.21e-05	0.000444	CcSEcCtD
Daunorubicin—Dizziness—Epirubicin—thyroid cancer	1.21e-05	0.000442	CcSEcCtD
Daunorubicin—ABCC1—Disease—TRIM33—thyroid cancer	1.2e-05	0.00103	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—TP53—thyroid cancer	1.2e-05	0.00103	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	1.19e-05	0.00102	CbGpPWpGaD
Daunorubicin—Pruritus—Doxorubicin—thyroid cancer	1.19e-05	0.000438	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.19e-05	0.00102	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—MINPP1—thyroid cancer	1.17e-05	0.000999	CbGpPWpGaD
Daunorubicin—Vomiting—Epirubicin—thyroid cancer	1.16e-05	0.000425	CcSEcCtD
Daunorubicin—SLC22A2—Metabolism—MINPP1—thyroid cancer	1.16e-05	0.000989	CbGpPWpGaD
Daunorubicin—Diarrhoea—Doxorubicin—thyroid cancer	1.15e-05	0.000424	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—TERT—thyroid cancer	1.15e-05	0.000987	CbGpPWpGaD
Daunorubicin—Rash—Epirubicin—thyroid cancer	1.15e-05	0.000422	CcSEcCtD
Daunorubicin—Dermatitis—Epirubicin—thyroid cancer	1.15e-05	0.000421	CcSEcCtD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.14e-05	0.000978	CbGpPWpGaD
Daunorubicin—Headache—Epirubicin—thyroid cancer	1.14e-05	0.000419	CcSEcCtD
Daunorubicin—CYP3A5—Biological oxidations—RXRA—thyroid cancer	1.14e-05	0.000974	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—HPGD—thyroid cancer	1.14e-05	0.000974	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NDUFA13—thyroid cancer	1.13e-05	0.000965	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDK1—thyroid cancer	1.12e-05	0.000957	CbGpPWpGaD
Daunorubicin—Dizziness—Doxorubicin—thyroid cancer	1.12e-05	0.000409	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—NRAS—thyroid cancer	1.11e-05	0.000949	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NDUFA13—thyroid cancer	1.09e-05	0.000934	CbGpPWpGaD
Daunorubicin—Nausea—Epirubicin—thyroid cancer	1.08e-05	0.000397	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.08e-05	0.000921	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—RXRA—thyroid cancer	1.08e-05	0.00092	CbGpPWpGaD
Daunorubicin—Vomiting—Doxorubicin—thyroid cancer	1.07e-05	0.000394	CcSEcCtD
Daunorubicin—Rash—Doxorubicin—thyroid cancer	1.06e-05	0.00039	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—thyroid cancer	1.06e-05	0.00039	CcSEcCtD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	1.06e-05	0.000908	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	1.06e-05	0.000908	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CHST14—thyroid cancer	1.06e-05	0.000908	CbGpPWpGaD
Daunorubicin—Headache—Doxorubicin—thyroid cancer	1.06e-05	0.000388	CcSEcCtD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.05e-05	0.000897	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	1.05e-05	0.000897	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.04e-05	0.000893	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.04e-05	0.000889	CbGpPWpGaD
Daunorubicin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	1.04e-05	0.000888	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.03e-05	0.000883	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	1.03e-05	0.000879	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CHST14—thyroid cancer	1.03e-05	0.000878	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—AKT1—thyroid cancer	1.01e-05	0.000866	CbGpPWpGaD
Daunorubicin—Nausea—Doxorubicin—thyroid cancer	1e-05	0.000368	CcSEcCtD
Daunorubicin—TOP2A—Circadian rythm related genes—PTEN—thyroid cancer	9.98e-06	0.000854	CbGpPWpGaD
Daunorubicin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.96e-06	0.000853	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NDUFA13—thyroid cancer	9.92e-06	0.000849	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NDUFA13—thyroid cancer	9.82e-06	0.000841	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	9.78e-06	0.000837	CbGpPWpGaD
Daunorubicin—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	9.71e-06	0.000831	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—KRAS—thyroid cancer	9.55e-06	0.000817	CbGpPWpGaD
Daunorubicin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	9.5e-06	0.000813	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CHST14—thyroid cancer	9.33e-06	0.000799	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—PPARG—thyroid cancer	9.27e-06	0.000793	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CHST14—thyroid cancer	9.23e-06	0.00079	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.23e-06	0.00079	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	9.22e-06	0.000789	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	9.22e-06	0.000789	CbGpPWpGaD
Daunorubicin—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	9.15e-06	0.000783	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	9.13e-06	0.000781	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	9.13e-06	0.000781	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.07e-06	0.000777	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.98e-06	0.000769	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—TPR—thyroid cancer	8.86e-06	0.000759	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	8.73e-06	0.000747	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PRKAR1A—thyroid cancer	8.72e-06	0.000746	CbGpPWpGaD
Daunorubicin—YWHAG—Membrane Trafficking—AKT1—thyroid cancer	8.6e-06	0.000736	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	8.57e-06	0.000733	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—HPGD—thyroid cancer	8.55e-06	0.000732	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	8.53e-06	0.00073	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MINPP1—thyroid cancer	8.36e-06	0.000716	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—HPGD—thyroid cancer	8.27e-06	0.000708	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—HRAS—thyroid cancer	8.11e-06	0.000695	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TERT—thyroid cancer	8.06e-06	0.00069	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TCF7L1—thyroid cancer	8.01e-06	0.000685	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.98e-06	0.000683	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.94e-06	0.000679	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MINPP1—thyroid cancer	7.9e-06	0.000676	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	7.9e-06	0.000676	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.85e-06	0.000672	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	7.61e-06	0.000651	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—HPGD—thyroid cancer	7.52e-06	0.000644	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CCND1—thyroid cancer	7.45e-06	0.000638	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—HPGD—thyroid cancer	7.44e-06	0.000637	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.29e-06	0.000624	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—AKT1—thyroid cancer	7.17e-06	0.000613	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NDUFA13—thyroid cancer	7.11e-06	0.000609	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	7.09e-06	0.000607	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.93e-06	0.000593	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.9e-06	0.000591	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—RXRA—thyroid cancer	6.86e-06	0.000587	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.83e-06	0.000585	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—thyroid cancer	6.81e-06	0.000583	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NDUFA13—thyroid cancer	6.72e-06	0.000575	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.71e-06	0.000574	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CHST14—thyroid cancer	6.69e-06	0.000572	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.67e-06	0.000571	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CCND1—thyroid cancer	6.66e-06	0.00057	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—SLC5A5—thyroid cancer	6.64e-06	0.000568	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.59e-06	0.000564	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—BRAF—thyroid cancer	6.57e-06	0.000562	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	6.55e-06	0.000561	CbGpPWpGaD
Daunorubicin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	6.55e-06	0.00056	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—TPR—thyroid cancer	6.53e-06	0.000559	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PRKAR1A—thyroid cancer	6.43e-06	0.00055	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CHST14—thyroid cancer	6.32e-06	0.000541	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MINPP1—thyroid cancer	6.31e-06	0.00054	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.99e-06	0.000513	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TPR—thyroid cancer	5.86e-06	0.000502	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.83e-06	0.000499	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.8e-06	0.000496	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PRKAR1A—thyroid cancer	5.77e-06	0.000494	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.74e-06	0.000491	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—RXRA—thyroid cancer	5.58e-06	0.000477	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	5.57e-06	0.000477	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MEN1—thyroid cancer	5.51e-06	0.000472	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HPGD—thyroid cancer	5.39e-06	0.000461	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NDUFA13—thyroid cancer	5.37e-06	0.000459	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.29e-06	0.000453	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—thyroid cancer	5.21e-06	0.000446	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HPGD—thyroid cancer	5.09e-06	0.000436	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CHST14—thyroid cancer	5.04e-06	0.000432	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MINPP1—thyroid cancer	5.04e-06	0.000431	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	4.99e-06	0.000427	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	4.99e-06	0.000427	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TPR—thyroid cancer	4.91e-06	0.00042	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.91e-06	0.00042	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—SLC5A5—thyroid cancer	4.89e-06	0.000419	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PRKAR1A—thyroid cancer	4.83e-06	0.000413	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TPR—thyroid cancer	4.75e-06	0.000406	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PRKAR1A—thyroid cancer	4.67e-06	0.0004	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CCND1—thyroid cancer	4.66e-06	0.000399	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	4.61e-06	0.000395	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.58e-06	0.000392	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—thyroid cancer	4.39e-06	0.000376	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CALCA—thyroid cancer	4.39e-06	0.000376	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.38e-06	0.000375	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TPR—thyroid cancer	4.32e-06	0.00037	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NDUFA13—thyroid cancer	4.28e-06	0.000367	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TPR—thyroid cancer	4.28e-06	0.000366	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PRKAR1A—thyroid cancer	4.25e-06	0.000364	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.23e-06	0.000362	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	4.21e-06	0.00036	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.13e-06	0.000353	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—RXRA—thyroid cancer	4.11e-06	0.000352	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HPGD—thyroid cancer	4.07e-06	0.000348	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CHST14—thyroid cancer	4.03e-06	0.000345	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4e-06	0.000342	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDK1—thyroid cancer	3.97e-06	0.00034	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.94e-06	0.000337	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.92e-06	0.000336	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.89e-06	0.000333	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.73e-06	0.000319	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC5A5—thyroid cancer	3.67e-06	0.000315	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—AKT1—thyroid cancer	3.67e-06	0.000314	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC5A5—thyroid cancer	3.55e-06	0.000304	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.54e-06	0.000303	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PPARG—thyroid cancer	3.52e-06	0.000301	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.44e-06	0.000295	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.42e-06	0.000293	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.33e-06	0.000285	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.31e-06	0.000283	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HPGD—thyroid cancer	3.25e-06	0.000278	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC5A5—thyroid cancer	3.23e-06	0.000277	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC5A5—thyroid cancer	3.2e-06	0.000274	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NRG1—thyroid cancer	3.19e-06	0.000273	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.14e-06	0.000268	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CHST14—thyroid cancer	3.11e-06	0.000266	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TPR—thyroid cancer	3.1e-06	0.000265	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—RXRA—thyroid cancer	3.09e-06	0.000264	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—thyroid cancer	3.07e-06	0.000263	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3.04e-06	0.000261	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—thyroid cancer	3.02e-06	0.000258	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3e-06	0.000257	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—RXRA—thyroid cancer	2.99e-06	0.000256	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TPR—thyroid cancer	2.92e-06	0.00025	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.9e-06	0.000249	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	2.88e-06	0.000246	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TERT—thyroid cancer	2.86e-06	0.000245	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—thyroid cancer	2.77e-06	0.000237	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HIF1A—thyroid cancer	2.74e-06	0.000234	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—RXRA—thyroid cancer	2.72e-06	0.000233	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—RXRA—thyroid cancer	2.69e-06	0.00023	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.63e-06	0.000225	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.63e-06	0.000225	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.61e-06	0.000223	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PPARG—thyroid cancer	2.6e-06	0.000222	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HPGD—thyroid cancer	2.51e-06	0.000214	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTEN—thyroid cancer	2.41e-06	0.000207	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TPR—thyroid cancer	2.34e-06	0.0002	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.34e-06	0.0002	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.32e-06	0.000198	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.3e-06	0.000197	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—BRAF—thyroid cancer	2.27e-06	0.000194	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC5A5—thyroid cancer	2.19e-06	0.000187	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.05e-06	0.000176	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—thyroid cancer	2.04e-06	0.000175	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.97e-06	0.000169	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARG—thyroid cancer	1.95e-06	0.000167	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—RXRA—thyroid cancer	1.95e-06	0.000167	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARG—thyroid cancer	1.89e-06	0.000161	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TPR—thyroid cancer	1.86e-06	0.00016	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—RXRA—thyroid cancer	1.84e-06	0.000157	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.83e-06	0.000157	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—thyroid cancer	1.83e-06	0.000157	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.79e-06	0.000153	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTEN—thyroid cancer	1.78e-06	0.000152	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.75e-06	0.00015	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARG—thyroid cancer	1.72e-06	0.000147	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARG—thyroid cancer	1.7e-06	0.000145	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.66e-06	0.000142	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTEN—thyroid cancer	1.6e-06	0.000137	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—thyroid cancer	1.53e-06	0.000131	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—thyroid cancer	1.48e-06	0.000127	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—RXRA—thyroid cancer	1.47e-06	0.000126	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TPR—thyroid cancer	1.44e-06	0.000123	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NRAS—thyroid cancer	1.42e-06	0.000122	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.42e-06	0.000121	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.4e-06	0.000119	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—thyroid cancer	1.39e-06	0.000119	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—thyroid cancer	1.35e-06	0.000115	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTEN—thyroid cancer	1.34e-06	0.000114	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—thyroid cancer	1.34e-06	0.000114	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.31e-06	0.000112	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTEN—thyroid cancer	1.29e-06	0.000111	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARG—thyroid cancer	1.23e-06	0.000105	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—thyroid cancer	1.23e-06	0.000105	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTEN—thyroid cancer	1.18e-06	0.000101	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—RXRA—thyroid cancer	1.17e-06	0.0001	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTEN—thyroid cancer	1.16e-06	9.97e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARG—thyroid cancer	1.16e-06	9.94e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.14e-06	9.76e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.08e-06	9.22e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—thyroid cancer	1.04e-06	8.92e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—thyroid cancer	1.03e-06	8.78e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—thyroid cancer	9.67e-07	8.28e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARG—thyroid cancer	9.27e-07	7.94e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—thyroid cancer	9.2e-07	7.88e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—thyroid cancer	9.13e-07	7.82e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—RXRA—thyroid cancer	9.05e-07	7.75e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTEN—thyroid cancer	8.43e-07	7.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTEN—thyroid cancer	7.97e-07	6.82e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—thyroid cancer	7.71e-07	6.6e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—thyroid cancer	7.45e-07	6.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARG—thyroid cancer	7.4e-07	6.34e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—thyroid cancer	7.3e-07	6.24e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—thyroid cancer	6.78e-07	5.8e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—thyroid cancer	6.71e-07	5.74e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTEN—thyroid cancer	6.36e-07	5.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.82e-07	4.98e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARG—thyroid cancer	5.71e-07	4.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTEN—thyroid cancer	5.08e-07	4.35e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—thyroid cancer	4.86e-07	4.16e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—thyroid cancer	4.59e-07	3.93e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.5e-07	3.85e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTEN—thyroid cancer	3.92e-07	3.36e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—thyroid cancer	3.67e-07	3.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—thyroid cancer	2.93e-07	2.51e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—thyroid cancer	2.26e-07	1.93e-05	CbGpPWpGaD
